Cogent Biosciences develops precision medicines for genetically defined diseases. Its main products are targeted drug candidates and clinical development services for patients, healthcare providers, and research partners in oncology and rare disease care.
Cogent Biosciences products and services overview:
Revenue: ~$0 million
Employees: 220
Headquarters: Waltham, United States (USA)
Cogent Biosciences is one of the...
Cogent Biosciences is a company listed under the stock ticker COGT (US).
View the org chart displaying its 36 main executives
Create your alert
to follow the executive moves at Cogent Biosciences.
Cogent Biosciences has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.